Immunohistochemical Analysis of Cell Proliferation and Bcl-2 Expression in Drug-Induced Gingival Overgrowth

Ana Luzia Araújo Batista, Angélica Kercya Pereira de Mendonça, Roseana de Almeida Freitas, Pollianna Muniz Alves, Gustavo Pina Godoy, Cassiano Francisco Weege Nonaka, Ruthineia Diógenes Alves Uchôa Lins


Objective: To compare the rate of cell proliferation and expression of antiapoptotic protein Bcl-2 between drug-induced gingival overgrowth (DIGO) and clinical healthy gingiva (CHG) and to establish associations with histopathological features. Material and Methods: Twenty specimens of DIGO and 20 CHG specimens were submitted to morphological and immunohistochemical analysis by light microscopy. Cell proliferation (Ki-67) and the expression of Bcl-2 were evaluated in epithelial cells and spindle-shaped mononuclear cells of the connective tissue by establishing the labeling index (LI). Results: In epithelial tissue, the mean LI for Ki-67 was 17.2% in DIGO and 21.71% in CHG (p = 0.137). The mean LIs for Bcl-2 in epithelial tissue were 14.67% and 10.24% in DIGO and CHG, respectively (p = 0.026). In connective tissue, DIGO and CHG specimens exhibited low LIs for Ki-67 and Bcl-2, with mean values of less than 0.5% in both groups. No significant differences in the LIs for Ki-67 or Bcl-2 in epithelial tissue were observed according to the degree of collagenization, degree of vascularization and intensity of inflammatory infiltration (p > 0.05). No significant correlations were observed between the LIs for Ki-67 and Bcl-2 (p > 0.05). Conclusion: The present results suggest that the pathogenesis of DIGO does not involve increased proliferation or decreased apoptosis of fibroblasts. On the other hand, the morphological pattern of elongated epithelial cristae observed in DIGO could mainly be due to the inhibition of keratinocyte apoptosis and not to increased proliferation of these cells.


Gingival Overgrowth; Ki-67 Antigen; Genes, bcl-2; Immunohistochemistry

Full Text:



Chang CW, Yang CJ, Lai YL. Phenytoin and amlodipine-induced gingival overgrowth. J Dent Sci 2012; 7(1):85-8. doi: 10.1016/j.jds.2012.01.013.

Buduneli N, Buduneli E, Cinar S, Lappin D, Kinane DF. Immunohistochemical evaluation of Ki-67 expression and apoptosis in cyclosporin A-induced gingival overgrowth. J Periodontol 2007; 78(2): 282-9. doi: 10.1902/jop.2007.060051.

Bharti V, Bansal C. Drug-induced gingival overgrowth: the nemesis of gingiva unravelled. J Indian Soc Periodontol 2013; 17(2):182-7. doi: 10.4103/0972-124X.113066.

Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis. Oral Dis 2015; 21(1):e51-e61. doi: 10.1111/odi.12264.

Saito K, Mori S, Tanda N, Sakamoto S. Immunolocalization of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontol 2000; 71(1):44-9. doi: 10.1902/jop.2000.71.1.44.

Handajani J, Santoso AL, Haniastuti T, Utoro T, Sosroseno W. Effect of nifedipine on the expression of bcl-2 protein in rat gingiva. Clin Oral Investig 2003; 7(1):56-8. doi: 10.1007/s00784-003-0194-7.

Nurmenniemi PK, Pernu HE, Knuuttila ML. Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 2001; 72(2):167-73. doi: 10.1902/jop.2001.72.2.167.

Mesa F, Aguilar M, Gonzalez-Moles MA, Guerrero A, Sanchez-Alvarez JC, Del Moral RG, et al. Vigabatrin-induced modification of Ki-67 expression in gingival epithelium: immunohistochemical study of a short series. J Periodontal Res 2004; 39(1):66-71. doi: 10.1111/j.1600-0765.2004.00711.x.

Bulut S, Ozdemir BH, Alaaddinoĝlu EE, Oduncuoĝlu FB, Bulut OE, Demirhan B. Effect of cyclosporin A on apoptosis and expression of p53 and bcl-2 proteins in gingiva of renal transplant patients. J Periodontol 2005; 76(5):691-5. doi: 10.1902/jop.2005.76.5.691.

Cetinkaya BO, Pamuk F, Keles GC, Ayas B, Ozfidan GK, Kaiysli U, et al. The role of phosphatase and tensin homolog in drug-induced gingival overgrowth. J Periodontal Res 2014; 49(3):307-13. doi: 10.1111/jre.12108.

Shimizu Y, Kataoka M, Seto H, Kido J, Nagata T. Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis. J Periodontol 2002; 73(8):861-7.

Sato N, Matsumoto H, Akimoto Y, Fujii A. The effect of IL-1alpha and nifedipine of cell proliferation and DNA synthesis in cultured human gingival fibroblasts. J Oral Sci 2005; 47(2):105-10.

Takeuchi R, Matsumoto H, Akimoto Y, Fujii A. Reduction in lipopolysaccharide-induced apoptosis of fibroblasts obtained from a patient with gingival overgrowth during nifedipine-treatment. Arch Oral Biol 2011; 56(10):1073-80. doi: 10.1016/j.archoralbio.2011.03.006.

Cota LOM, Viana MB, Moreira PR, Gomez RS, Cortelli JR, Cortelli SC, et al. Gingival overgrowth in cyclosporine, tacrolimus, or sirolimus-based immunosuppressive regimens and the single nucleotide IL-6 (-174 G/C) gene polymorphism. Arch Oral Biol 2010; 55(7):494-501.

Bulut S, Ozdemir BH. Apoptosis and expression of caspase-3 in cyclosporin-induced gingival overgrowth. J Periodontol 2007; 78(12):2364-8. doi: 10.1902/jop.2007.070226.

Corrêa JD, Queiroz-Junior CM, Costa JE, Teixeira AL, Silva TA. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN Dent 2011; 497850. doi: 10.5402/2011/497850.

Bulut OE, Sökmensüer LK, Bulut S, Tasman F, Müftüoğlu S. Immunohistochemical study of cyclosporin-induced gingival overgrowth in renal transplant recipients. J Periodontol 2004; 75(12):1655-62. doi: 10.1902/jop.2004.75.12.1655.

Saito K, Mori S, Tanda N, Sakamoto S. Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontol 1999; 70(6):581-6. doi: 10.1902/jop.1999.70.6.581.

Arunachalam LT, Rao S. Immunolocalization of Bcl-2 oncoprotein in amlodipine-induced gingival overgrowth. Indian J Dent Res 2013; 24(2):255-60.

Pisoschi CG, Stănciulescu CE, Andrei AM, Berbecaru-Iovan A, Munteanu C, Popescu F, et al. Role of transforming growth factor β-connective tissue growth factor pathway in dihydropyridine calcium channel blockers-induced gingival overgrowth. Rom J Morphol Embriol 2014; 55(2):285-90.

Takeuchi R, Matsumoto H, Akimoto Y, Fujii A. Inhibition of G1 cell cycle arrest in human gingival fibroblasts exposed to phenytoin. Fundam Clin Pharmacol 2014; 28(1):114-9. doi: 10.1111/j.1472-8206.2012.01065.x.

Spolidorio LC, Spolidorio DM, Holzhausen M, Nassar PO, Nassar CA. Effects of long-term cyclosporin therapy on gingiva of rats - analysis by stereological and biochemical estimation. Braz Oral Res 2005; 19(2):112-8. doi: 10.1590/S1806-83242005000200007.

Trackman PC, Kantarci A. Molecular and clinical aspects of drug-induced gingival overgrowth. J Dent Res 2015; 94(4):540-6. doi: 10.1177/0022034515571265.

Uzel MI, Kantarci A, Hong HH, Uygur C, Sheff MC, Firatli E, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001; 72(7):921-31. doi: 10.1902/jop.2001.72.7.921.

Kim SS, Jackson-Boeters L, Darling MR, Rieder MJ, Hamilton DW. Nifedipine induces periostin expression in gingival fibroblasts through TGF-beta. J Dent Res 2013; 92(11):1022-8. doi: 10.1177/0022034513503659.